Cytokinetics, Inc. Share Price Nasdaq
Stocks
US23282W1009
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-14 | Cytokinetics Insider Sold Shares Worth $615,150, According to a Recent SEC Filing | MT |
| 07-07 | RBC Capital Adjusts Cytokinetics Price Target to $117 From $119, Maintains Outperform Rating | MT |
| Market Cap | 11.22B 9.81B 9.05B 8.32B 15.76B 1,079B 16.03B 108B 42.38B 528B 42.13B 41.2B 1,818B | P/E 2026 * |
-12.9x | P/E 2027 * | -17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 10.63B 9.3B 8.58B 7.88B 14.94B 1,023B 15.19B 102B 40.17B 500B 39.93B 39.06B 1,724B | EV / Sales 2026 * |
95.1x | EV / Sales 2027 * | 27x |
| Free-Float |
98.24% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytokinetics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 62 | 31/12/2006 |
Sung Lee
DFI | Director of Finance/CFO | 55 | 07/05/2024 |
| Chief Administrative Officer | 57 | 13/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Blum
BRD | Director/Board Member | 62 | 31/12/2006 |
John Henderson
CHM | Chairman | 81 | 07/04/2022 |
Wendell Wierenga
BRD | Director/Board Member | 78 | 08/02/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.13% | +13.95% | +64.21% | +94.35% | 57.82B | |
| -0.37% | -6.20% | +53.79% | +70.80% | 53.71B | |
| -3.58% | -5.77% | +6.75% | +433.06% | 23.8B | |
| -0.01% | -1.65% | -16.86% | -15.01% | 23.26B | |
| -0.56% | +6.10% | +44.56% | -3.75% | 20.7B | |
| -2.12% | -2.88% | +33.27% | -30.21% | 17.81B | |
| +10.00% | -4.30% | +208.33% | +370.99% | 16.9B | |
| -2.61% | +10.00% | +47.02% | +699.54% | 16.36B | |
| -0.31% | -1.00% | +26.08% | +186.49% | 13.96B | |
| Average | +0.36% | +1.42% | +51.90% | +200.70% | 27.15B | |
| Weighted average by Cap. | +0.56% | +1.35% | +51.32% | +159.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 112M 97.77M 90.19M 82.91M 157M 10.76B 160M 1.08B 422M 5.26B 420M 411M 18.13B | 393M 344M 317M 291M 552M 37.82B 562M 3.79B 1.49B 18.49B 1.48B 1.44B 63.72B |
| Net income | -798M -698M -644M -592M -1.12B -76.83B -1.14B -7.69B -3.02B -37.55B -3B -2.93B -129B | -653M -571M -527M -484M -917M -62.84B -933M -6.29B -2.47B -30.71B -2.45B -2.4B -106B |
| Net Debt | -583M -510M -471M -433M -820M -56.14B -834M -5.62B -2.2B -27.44B -2.19B -2.14B -94.58B | -601M -525M -484M -445M -844M -57.79B -858M -5.78B -2.27B -28.25B -2.26B -2.21B -97.35B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
